*Corresponding author:
Francois-Xavier Lacasse, Faculty of Pharmacy, University of Montreal, 2940 Chemin de Polytechnique, Montreal, Quebec, CanadaReceived: June 16, 2018; Published: June 20, 2018
DOI: 10.26717/BJSTR.2018.05.001271
To view the Full Article Peer-reviewed Article PDF
Building a safety assessment package to go into the Phase I clinical stage sounds simple enough.
Short Communication | Absorption, Distribution, Metabolism, Excretion (ADME) | Conclusions and Final Thoughts |
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Neurology, LA BioMed Research Institute, USA
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Clinical Radiologist (MD) - Department of RADIOLOGY, Cosenza Hospital, Cosenza, Italy